IGC Pharma
IGC
IGC Pharma (IGC) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Ascendiant Capital | Maintained | Buy | $6.00 from $5.50 | Aug 26, 2026 |
| Ascendiant Capital | Maintained | Buy | $5.50 from $5.25 | Jun 8, 2026 |
| Ascendiant Capital | Maintained | Buy | $5.25 from $5.00 | Apr 8, 2026 |
| Ascendiant Capital | Maintained | Buy | $5.00 from $4.75 | Feb 23, 2026 |
| Ascendiant Capital | Maintained | Buy | $4.75 from $4.50 | Dec 9, 2025 |
| Ascendiant Capital | Maintained | Buy | $4.50 from $4.25 | Aug 26, 2025 |
| Alliance Global Partners | Maintained | Buy | $3.50 | Mar 6, 2025 |
| Ascendiant Capital | Maintained | Buy | $4.25 from $4.00 | Feb 24, 2025 |
| Ascendiant Capital | Maintained | Buy | $4.00 from $3.75 | Dec 5, 2024 |
| Ascendiant Capital | Maintained | Buy | $3.75 from $3.50 | Sep 3, 2024 |
| Ascendiant Capital | Maintained | Buy | $3.50 from $3.25 | Jul 29, 2024 |
| Alliance Global Partners | Initiated Coverage | Buy | $3.50 | Jul 17, 2024 |
| Ascendiant Capital | Maintained | Buy | $3.25 | Jun 21, 2024 |
Frequently asked questions
What is the latest analyst rating on IGC?
On Aug 26, 2026, Ascendiant Capital maintained IGC Pharma at Buy with a price target of $6.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.